Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1SANOFI AVENTIS US
02 1DR REDDYS
03 6DR REDDYS LABS SA
04 2ETHYPHARM
05 1MANKIND PHARMA
06 4ABRAXIS PHARM
07 2ACCORD HLTHCARE
08 2ACTAVIS ELIZABETH
09 1ACTAVIS LABS UT INC
10 3ADAPT
11 2ALKEM LABS LTD
12 4ALVOGEN
13 1AMNEAL
14 2AMNEAL PHARMS
15 1AMPHASTAR PHARMS INC
16 2ASCENT PHARMS INC
17 1ASTRAZENECA
18 3BAXTER HLTHCARE CORP
19 3BDSI
20 1BPI LABS
21 3BRISTOL MYERS SQUIBB
22 1CHARTWELL RX
23 4DIFGEN PHARMS
24 2EMERGENT
25 3EUGIA PHARMA
26 2FRESENIUS KABI USA
27 1HARM REDUCTION THERP
28 13HIKMA
29 8HOSPIRA
30 12IGI LABS INC
31 6INDIVIOR
32 4INTL MEDICATION
33 3KALEO INC
34 2LANNETT CO INC
35 1LUPIN
36 1MARSAM PHARMS LLC
37 2MYLAN INSTITUTIONAL
38 1MYLAN LABS LTD
39 4MYLAN TECHNOLOGIES
40 6OREXO US INC
41 2PADAGIS ISRAEL
42 2PH HEALTH
43 3PURDUE PHARMA LP
44 3QUAD PHARMS
45 2RHODES PHARMS
46 2RISING
47 1SCIENTURE
48 3SMITH AND NEPHEW
49 2SOLOPAK
50 2SOMERSET THERAPS LLC
51 2SPECGX LLC
52 1STERINOVA INC
53 2SUN PHARM
54 1SUN PHARM INDS LTD
55 6SUN PHARM INDUSTRIES
56 4TEVA PHARMS USA
57 2WATSON LABS
58 2WES PHARMA INC
59 4WYETH AYERST
60 1ZMI PHARMA
01 3FILM;BUCCAL
02 21FILM;BUCCAL, SUBLINGUAL
03 1FILM;SUBLINGUAL
04 79INJECTABLE;INJECTION
05 3Injectable; Injection
06 4SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS
07 7SPRAY, METERED;NASAL
08 4SPRAY;NASAL
09 3TABLET, EXTENDED RELEASE;ORAL
10 4TABLET;ORAL
11 40TABLET;SUBLINGUAL
01 71DISCN
02 5OTC
03 81RX
04 12Blank
01 3BUNAVAIL
02 48BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
03 1BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
04 1CASSIPA
05 1EVZIO
06 1EVZIO (AUTOINJECTOR)
07 2KLOXXADO
08 7NALOXONE
09 3NALOXONE HCL
10 70NALOXONE HYDROCHLORIDE
11 1NALOXONE HYDROCHLORIDE (AUTOINJECTOR)
12 3NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE
13 8NARCAN
14 1REXTOVY
15 1REZENOPY
16 1RIVIVE
17 6SUBOXONE
18 1TALWIN NX
19 3TARGINIQ
20 1ZIMHI
21 6ZUBSOLV
01 124No
02 33Yes
03 12Blank
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RLD : No
TE Code :
NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE
Brand Name : TALWIN NX
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 0.5MG BASE;EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1982-12-16
Application Number : 18733
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Brand Name : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : FILM;BUCCAL, SUBLINGUAL
Dosage Strength : EQ 2MG BASE;EQ 0.5MG BASE
Approval Date : 2018-06-14
Application Number : 205299
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.
RLD : No
TE Code : AB
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Brand Name : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : TABLET;SUBLINGUAL
Dosage Strength : EQ 2MG BASE;EQ 0.5MG BASE
Approval Date : 2015-10-16
Application Number : 204431
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
RLD : No
TE Code : AP
Brand Name : NALOXONE HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 0.4MG/ML
Approval Date : 2024-02-29
Application Number : 218404
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Brand Name : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : FILM;BUCCAL, SUBLINGUAL
Dosage Strength : EQ 8MG BASE;EQ 2MG BASE
Approval Date : 2018-06-14
Application Number : 205299
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Brand Name : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : FILM;BUCCAL, SUBLINGUAL
Dosage Strength : EQ 4MG BASE;EQ 1MG BASE
Approval Date : 2018-06-14
Application Number : 205806
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Brand Name : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : FILM;BUCCAL, SUBLINGUAL
Dosage Strength : EQ 12MG BASE;EQ 3MG BASE
Approval Date : 2018-06-14
Application Number : 205806
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Brand Name : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : TABLET;SUBLINGUAL
Dosage Strength : EQ 2MG BASE;EQ 0.5MG BASE
Approval Date : 2020-07-17
Application Number : 206953
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Brand Name : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : TABLET;SUBLINGUAL
Dosage Strength : EQ 8MG BASE;EQ 2MG BASE
Approval Date : 2020-07-17
Application Number : 206953
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AP
Brand Name : NALOXONE HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 1MG/ML
Approval Date : 2020-03-16
Application Number : 213209
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
